Colleen Badgley

Partner
Full contact info

Experience

Kimia Therapeutics Closes $55 Million Series A

December 19, 2023

Cooley advised Kimia Therapeutics on its $55 million Series A financing. Partner Josh Seidenfeld led the Cooley team advising Kimia Therapeutics, which is a drug discovery platform that uncovers novel biological insights through precision chemistry and machine learning.

Read more

Related contacts

Josh Seidenfeld
Partner, Palo Alto
Karen Gustavson
Associate, Seattle
Rachel Robichaux
Associate, Palo Alto
Phoebe Huang
Associate, Seattle
Meg Begur
Associate, London
Colleen Badgley
Partner, Seattle

Related Practices & Industries

Parse Biosciences Closes $50 Million Series C

December 14, 2023

Cooley advised Parse Biosciences on its $50 million Series C financing. Partner Sonya Erickson led the Cooley team advising Parse Biosciences, which develops single-cell sequencing products used by more than 1,000 labs worldwide.

Read more

Related contacts

Sonya Erickson
Partner and Business Department Chair, Seattle
Lucy Bauer
Associate, Seattle
Willy Cowles
Associate, Seattle
Yuri Weigel
Special Counsel, Seattle
Scott Lin
Associate, San Francisco
Colleen Badgley
Partner, Seattle

Related Practices & Industries

Cooley Advises Instacart on $660 Million IPO

September 19, 2023

Cooley advised Instacart, the leading grocery technology company in North America, on its $660 million initial public offering.

Read more

Related contacts

Jon Avina
Partner, Palo Alto
Rachel Proffitt
Partner and Chief Executive Officer, San Francisco
Jonie Ing Kondracki
Partner, San Francisco
Milson Yu
Partner, Palo Alto
Nyron J. Persaud
Partner, New York
Kate Nichols
Partner, Palo Alto
Colleen Badgley
Partner, Seattle
Arielle H. Friehling
Associate, San Francisco
Julia Gage
Associate, San Francisco
Lukhan Baloch
Associate, Palo Alto
Jonathan Gonzalez
Associate, Palo Alto
Eric Steiner
Paralegal Specialist, San Francisco

Related Practices & Industries

Bonum Therapeutics Closes $93 Million Series A Financing

November 15, 2022

Cooley advised Bonum Therapeutics, a biopharmaceutical company focused on creating highly active and less toxic medicines, on its $93 million Series A financing. Partner Sonya Erickson led the Cooley team advising Bonum Therapeutics.

Related contacts

Sonya Erickson
Partner and Business Department Chair, Seattle
Colleen Badgley
Partner, Seattle
Brian Woodard
Paralegal Specialist, Seattle
Arlo Sporn
Associate, Seattle

Related Practices & Industries

General Catalyst Leads Eleanor Health’s $50 Million Series C

May 26, 2022

Cooley advised General Catalyst as lead investor in Eleanor Health’s $50 million Series C funding round. Eleanor Health is a provider of evidence-based outpatient care and addiction recovery services intended to help people suffering from substance abuse disorder. Partners Michael Rohr, Phil Mitchell, William Corcoran and Thomas Connors led the Cooley team.

Related contacts

Michael Rohr
Partner, Boston
Phil Mitchell
Partner, New York
William Corcoran
Of Counsel, Boston
Thomas Connors
Partner, Boston
Colleen Badgley
Partner, Seattle
Patrick Sharma
Associate, Los Angeles Santa Monica
Eric Popp
Associate, Boston
Jennifer Shanley
Special Counsel, New York

Related Practices & Industries

View more